EtiraRX has filed a notice of an exempt offering of securities to raise $10,595,149.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, EtiraRX is raising $10,595,149.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Russell Hayward played a key role in…